Gillian Mitchell

15.1k total citations · 3 hit papers
113 papers, 6.3k citations indexed

About

Gillian Mitchell is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Gillian Mitchell has authored 113 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Genetics, 36 papers in Oncology and 27 papers in Pathology and Forensic Medicine. Recurrent topics in Gillian Mitchell's work include BRCA gene mutations in cancer (71 papers), Genetic factors in colorectal cancer (21 papers) and Ovarian cancer diagnosis and treatment (19 papers). Gillian Mitchell is often cited by papers focused on BRCA gene mutations in cancer (71 papers), Genetic factors in colorectal cancer (21 papers) and Ovarian cancer diagnosis and treatment (19 papers). Gillian Mitchell collaborates with scholars based in Australia, United Kingdom and United States. Gillian Mitchell's co-authors include Michael Friedländer, Susan M. Domchek, M. William Audeh, Stephen B. Fox, Judith Balmañà, Bella Kaufman, Georgeta Fried, Ronnie Shapira‐Frommer, Niklas Loman and David D.L. Bowtell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Gillian Mitchell

113 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

2010 1.3k citations Susan M. Domchek, Gillian Mitchell et al. profile →
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

2014 1.2k citations Gillian Mitchell, Susan M. Domchek et al. profile →
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

2012 853 citations Kathryn Alsop, Anna DeFazio et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gillian Mitchell Australia	29	3.5k	2.6k	2.5k	1.4k	1.4k	113	6.3k
Judith Balmañà Spain	36	3.9k 1.1×	2.6k 1.0×	2.4k 1.0×	1.6k 1.1×	996 0.7×	179	6.5k
M. Kaufmann Germany	41	3.6k 1.0×	1.6k 0.6×	1.2k 0.5×	2.5k 1.7×	538 0.4×	242	6.5k
Helen Mackay Canada	41	2.9k 0.8×	2.9k 1.1×	644 0.3×	1.3k 0.9×	2.2k 1.5×	185	7.1k
E. Kubista Austria	43	3.7k 1.0×	2.0k 0.8×	1.6k 0.6×	2.4k 1.6×	334 0.2×	247	6.8k
David S.P. Tan Singapore	37	2.5k 0.7×	2.2k 0.9×	664 0.3×	1.5k 1.0×	1.3k 0.9×	181	5.1k
Helga B. Salvesen Norway	49	1.6k 0.5×	3.0k 1.2×	762 0.3×	1.5k 1.0×	1.8k 1.3×	153	6.9k
Hal W. Hirte Canada	45	3.7k 1.0×	3.2k 1.3×	803 0.3×	977 0.7×	2.3k 1.6×	156	8.1k
Anitra Fielding United Kingdom	24	3.7k 1.1×	1.9k 0.7×	1.1k 0.4×	699 0.5×	1.5k 1.0×	57	5.0k
Werner Meier Germany	32	3.3k 0.9×	1.6k 0.6×	1.0k 0.4×	531 0.4×	3.2k 2.2×	166	5.8k
Antonis C. Antoniou United Kingdom	42	2.1k 0.6×	2.0k 0.8×	4.6k 1.8×	1.8k 1.3×	588 0.4×	130	6.8k

Countries citing papers authored by Gillian Mitchell

Since Specialization

Citations

This map shows the geographic impact of Gillian Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Mitchell more than expected).

Fields of papers citing papers by Gillian Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Mitchell. The network helps show where Gillian Mitchell may publish in the future.

Co-authorship network of co-authors of Gillian Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Mitchell. A scholar is included among the top collaborators of Gillian Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Mitchell. Gillian Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petelin, Lara, et al.. (2020). Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers. Genetics in Medicine. 22(5). 831–839. 20 indexed citations

Petelin, Lara, et al.. (2019). A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAre. Value in Health. 22(8). 854–862. 9 indexed citations

Meiser, Bettina, Veronica Quinn, Gillian Mitchell, et al.. (2018). Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history. European Journal of Human Genetics. 26(7). 972–983. 12 indexed citations

Forrest, Laura, Gillian Mitchell, Lara Petelin, et al.. (2017). Consumer attitudes towards the establishment of a national Australian familial cancer research database by the Inherited Cancer Connect (ICCon) Partnership. Journal of Community Genetics. 9(1). 57–64. 5 indexed citations

Yanes, Tatiane, Bettina Meiser, Mary‐Anne Young, et al.. (2017). Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study. BMC Cancer. 17(1). 491–491. 10 indexed citations

Quinn, Veronica, Bettina Meiser, Judy Kirk, et al.. (2016). Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial. Genetics in Medicine. 19(4). 448–456. 26 indexed citations

Chen, Yanni, Michelle Peate, Rajneesh Kaur, et al.. (2016). Exploring clinicians’ attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer. Familial Cancer. 16(1). 99–109. 6 indexed citations

Douma, Kirsten F. L., Bettina Meiser, Judy Kirk, et al.. (2014). Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer. Familial Cancer. 14(2). 265–272. 12 indexed citations

Etemadmoghadam, Dariush, Barbara A. Weir, George Au‐Yeung, et al.. (2013). Synthetic lethality between CCNE1 amplification and loss of BRCA1. Proceedings of the National Academy of Sciences. 110(48). 19489–19494. 157 indexed citations

10.

George, Joshy, Kathryn Alsop, Dariush Etemadmoghadam, et al.. (2013). Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with BRCA1 and BRCA2 Mutations. Clinical Cancer Research. 19(13). 3474–3484. 67 indexed citations

11.

Young, Mary‐Anne, Amy S. Herlihy, Gillian Mitchell, et al.. (2013). The attitudes of people with sarcoma and their family towards genomics and incidental information arising from genetic research. PubMed. 3(1). 11–11. 11 indexed citations

12.

Mikeska, Thomas, et al.. (2013). No evidence for PALB2 methylation in high-grade serous ovarian cancer. Journal of Ovarian Research. 6(1). 26–26. 7 indexed citations

13.

Collins, Ian, Susan M. Domchek, David G. Huntsman, & Gillian Mitchell. (2011). The tubal hypothesis of ovarian cancer: caution needed. The Lancet Oncology. 12(12). 1089–1091. 24 indexed citations

14.

Mitchell, Gillian, Sandra Johnson, Lisa Devereux, et al.. (2010). Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 19(1). 265–274. 22 indexed citations

15.

Kiely, Belinda E., et al.. (2010). Practicalities of developing a breast magnetic resonance imaging screening service for women at high risk for breast cancer. ANZ Journal of Surgery. 81(10). 688–693. 2 indexed citations

16.

Mitchell, Gillian, William K. Murray, Judy Kirk, et al.. (2005). Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Research. 7(6). R1122–31. 19 indexed citations

17.

Vaghadia, Himat, et al.. (2002). Small-Dose Selective Spinal Anesthesia for Short-Duration Outpatient Laparoscopy: Recovery Characteristics Compared with Desflurane Anesthesia. Anesthesia & Analgesia. 94(2). 346–350. 39 indexed citations

18.

Mitchell, Gillian & Rosalind A. Eeles. (2002). The genetics of breast cancer. The Journal of the British Menopause Society. 8(1). 24–29. 4 indexed citations

19.

Chilvers, Colin R., A. P. L. Goodwin, Himat Vaghadia, & Gillian Mitchell. (2001). Selective spinal anesthesia for outpatient laparoscopy. V: Pharmacoeconomic comparisonvs general anesthesia. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 48(3). 279–283. 20 indexed citations

20.

Kote‐Jarai, Zsofia, S. Ashley, DF Easton, et al.. (2000). BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial. Breast Cancer Research. 2(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact